Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Abrocitinib may effectively treat stubborn alopecia universalis.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.